|
" Molecular Cancer Therapeutics: "
George C Prendergast
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
723044
|
| Doc. No
|
:
|
b542758
|
| Main Entry
|
:
|
George C Prendergast
|
| Title & Author
|
:
|
Molecular Cancer Therapeutics: : Strategies for Drug Discovery and Developmen.\ George C Prendergast
|
| Publication Statement
|
:
|
John Wiley & Sons, 2004
|
| Page. NO
|
:
|
351 s
|
| ISBN
|
:
|
0471432024
|
|
|
:
|
: 9780471432029
|
| Contents
|
:
|
Preface.Contributors.Chapter 1. Introduction (G. Prendergast).Chapter 2. Molecular Cancer Therapeutics: Will the Promise Be Fulfilled? (B. Teicher).Chapter 3. Cancer Genetics and Drug Target Selection (G. Zhang & W. Kaelin).Chapter 4. RNA Interference in Mammals: Journey to the Center of Human Disease (P. Paddison & G. Hannon).Chapter 5. Applications and Issues for Tissue Arrays in Target and Drug Discovery (E. Jonasch, K. Do, C. Logothetis, & T. McDonnell).Chapter 6. Protein Transduction Strategies for Target and Mechanism Validation (S. Ezhevsky & S. Dowdy).Chapter 7. Drug Screening: Assay Development Issues (S. Carroll, J. Inglese, S. Mao, & D. Olson).Chapter 8. Gene Microarray Technologies for Cancer Drug Discovery and Development (R. te Poele, P. Clarke, & P. Workman).Chapter 9. Transgenic Mouse Models of Cancer (T. Bowen & A. Wynshaw-Boris).Chapter 10. Transgenic versus Xenograft Mouse Models of Cancer: Utility and Issues (M. Liu, W. Bishop, Y. Wang, & P. Kirschmeier).Chapter 11. Pharmacodynamic Assays in Cancer Drug Discovery: From Preclinical Validation to Clinical Trial Monitoring (R. Lobell, N. Kohl, & L. Sepp-Lorenzino).Chapter 12. Pharmacokinetic and Toxicology Issues in Cancer Drug Discovery and Development (P. Benfield & B. Car).Chapter 13. Clinical Development Issues (S. Averbuch, M. Wolf, B. El-Rayes, & P. LoRusso).Chapter 14. Intellectual Property and Commercialization Issues in Drug Discovery (L. Malseed).Index.
|
| LC Classification
|
:
|
RC271.C5G467 2004
|
| Added Entry
|
:
|
George C Prendergast
|
| |